Polygenic Stroke Risk and Autoimmune Disease: Associations and Clinical Modifiers
IEEE Transactions on Biomedical Engineering · 2026-08 · 73 (8) · 2972-2983
DOI: 10.1109/tbme.2026.3702042 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Transactions on Biomedical Engineering, 2026-08. Verfasst von Andrew Hornback und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Stroke, Autoimmune Diseases, Genetic Predisposition to Disease, Multifactorial Inheritance. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Accelerate Foundation Models Academic Research Initiative from Microsoft Research, Wallace H. Coulter Distinguished Faculty Fellowship, Petit Institute Faculty Fellowship.
Themen: Schlaganfall
Abstract (Originalsprache)
Polygenic risk scores (PRSs) can improve prediction of complex diseases, but their utility may vary across clinical subgroups with distinct inflammatory or immunologic profiles. Because autoimmune diseases involve chronic immune dysregulation, they may influence both baseline stroke risk and the added value of genetic information in risk prediction. Using the U.K. Biobank, we identified individuals with prevalent autoimmune diseases at baseline and evaluated whether PRSs differentially improve 10-year incident stroke prediction in those with versus without autoimmune disease. We modeled 10-year incident stroke using logistic regression, gradient boosting, and XGBoost with demographic, ancestry, and clinical covariates, with and without PRSs. To quantify individual-level PRS contribution, we compared prediction error between non-genetic (NG)-only and NG+PRS models, defining subgroups in which predictions improved or worsened after inclusion of PRSs. We further examined enrichment of autoimmune conditions using approximately 3,600 clinical features across these subgroups. We find that elevated baseline stroke risk in individuals with autoimmune disease reduces the incremental predictive benefit of PRSs, consistent with established evidence linking immune-mediated disease to cerebrovascular risk. By integrating large-scale clinical phenotypes, genetic risk scores, autoimmune status, and longitudinal outcomes within a unified modeling framework, this study reproduces known clinical relationships and quantifies interactions between genetic and immune-mediated risk. Overall, these results clarify when genetic risk adds meaningful predictive value beyond strong clinical signals and highlight a scalable approach for identifying context-dependent utility of PRSs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Förderung
- Accelerate Foundation Models Academic Research Initiative from Microsoft Research
- Wallace H. Coulter Distinguished Faculty Fellowship
- Petit Institute Faculty Fellowship
- Amazon and Microsoft Research
Zitieren
APA
Hornback, A., Wang, Y., Piazzi, M., Sathu, H., Kim, K., Avula, P., Isgut, M., & Wang, M. D. (2026). Polygenic Stroke Risk and Autoimmune Disease: Associations and Clinical Modifiers. IEEE Transactions on Biomedical Engineering, 73(8), 2972-2983. https://doi.org/10.1109/tbme.2026.3702042
Vancouver
Hornback A, Wang Y, Piazzi M, Sathu H, Kim K, Avula P, et al. Polygenic Stroke Risk and Autoimmune Disease: Associations and Clinical Modifiers. IEEE Transactions on Biomedical Engineering. 2026;73(8):2972-2983. doi:10.1109/tbme.2026.3702042
BibTeX
@article{Hornback2026,
author = {Hornback, Andrew and Wang, Yifei and Piazzi, Marco and Sathu, Harinishree and Kim, Kyungbeom and Avula, Pavithra and Isgut, Monica and Wang, May D},
title = {Polygenic Stroke Risk and Autoimmune Disease: Associations and Clinical Modifiers},
journal = {IEEE Transactions on Biomedical Engineering},
year = {2026},
volume = {73},
number = {8},
pages = {2972--2983},
doi = {10.1109/tbme.2026.3702042}
}
EUVIMED